Home > Press Room > News

BPYT: Launch of Curemisinin(TM) All-Natural Anti-Malaria Product

Ridgeland, MS, NOV 13, 2007 (EventX/Knobias.com via COMTEX) -- By Fain Hughes, fhughes@knobias.comKnobias logo

Bioponic Phytoceuticals, Inc. (BPYT) announced the launch of Curemisinin(TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs (Artemesia, Turmeric and Cinchona Bark) extracted through the Company's proprietary extraction/distillation technologies. This binary product comprises a nasal spray (Curemisinin A) with an oral spray (Curemisinin B) to treat malaria.

NOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.

ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)